Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents

Details for Australian Patent Application No. 2002231049 (hide)

Owner Schering Corporation

Inventors Zbaida, Shmuel; Alton, Kevin B.; Iannucci, Robert M.; Davis, Harry R; Feng, Wenqing; Patrick, James E; Chowdhury, Swapan K; Ghosal, Anima

Agent Griffith Hack

Pub. Number AU-B-2002231049

PCT Pub. Number WO02/50090

Priority 60/256,875 20.12.00 US

Filing date 17 December 2001

Wipo publication date 1 July 2002

Acceptance publication date 20 July 2006

International Classifications

C07H 15/26 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/70 (2006.01) - Carbohydrates

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07D 205/08 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

Event Publications

20 July 2006 Application Accepted

  Published as AU-B-2002231049

16 November 2006 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002231050

2002231048